Weiss Multi-Strategy Advisers’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-11,000	Closed	-$19K	–	776
2019 Q3	$19K	Hold	11,000	–	–	﹤0.01%	564
2019 Q2	$52K	Hold	11,000	–	–	﹤0.01%	483
2019 Q1	$71K	Buy	+11,000	New	+$57.6K	﹤0.01%	494
2018 Q3	–	Sell	-71,981	Closed	-$907K	–	715
2018 Q2	$907K	Buy	+71,981	New	+$986K	0.02%	448

Other funds holding NTGN

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HMC

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Weiss Multi-Strategy Advisers's NTGN Position: Q4 2019 in Review

Weiss Multi-Strategy Advisers sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q4 2019, closing a stake of 11,000 shares — an estimated $19K sold.

Weiss Multi-Strategy Advisers first reported a position in NTGN in Q2 2018 and held it in 4 quarters. The position peaked at $907K in Q2 2018. 46 funds tracked by Wall St. Rank hold NTGN as of Q4 2019.

Weiss Multi-Strategy Advisers reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 11,000 Neon Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $19K.
Weiss Multi-Strategy Advisers first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
Weiss Multi-Strategy Advisers's Neon Therapeutics, Inc. Common Stock position peaked at $907K in Q2 2018.
46 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.